Track record
Jake Bauer
An officer, director or large holder of 4 blank-check companies. Every role below was declared by Jake Bauer in an SEC ownership filing.
Vehicles
4
Still live
0
Closed a deal
3 of 4
Capital involved
$499M
Every vehicle, newest first
- BridgeBio Oncology Therapeutics, Inc.BBOT · Director · IPO Feb 13, 2024$197MCompleted
- ARYA Sciences Acquisition Corp V— · Director · IPO Jul 14, 2021$153MLiquidated
- Cerevel Therapeutics Holdings, Inc.— · Director · IPO Jun 8, 2020$150MCompleted
- Immunovant, Inc.IMVT · Director · IPO May 11, 2019Completed
Compiled from Forms 3 and 3/A filed with the SEC under CIK 1654909. Roles are as declared at the time of filing and may have changed since. Nothing here is a judgement about any individual.